Search by Drug Name or NDC

NDC 51991-0312-14 Desvenlafaxine 100 mg/1 Details

Desvenlafaxine 100 mg/1

Desvenlafaxine is a ORAL TABLET, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Breckenridge Pharmaceutical, Inc. The primary component is DESVENLAFAXINE SUCCINATE.

MedlinePlus Drug Summary

Desvenlafaxine is used to treat depression. Desvenlafaxine is in a class of medications called selective serotonin and norepinephrine reuptake inhibitors (SNRIs). It works by increasing the amounts of serotonin and norepinephrine, natural substances in the brain that help maintain mental balance.

Related Packages: 51991-0312-14
Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Desvenlafaxine

Product Information

NDC	51991-0312
Product ID	51991-312_16c3e5ec-6bf4-4426-9f87-3279beca98a2
Associated GPIs	58180020207540
GCN Sequence Number	063737
GCN Sequence Number Description	desvenlafaxine succinate TAB ER 24H 100 MG ORAL
HIC3	H7C
HIC3 Description	SEROTONIN-NOREPINEPHRINE REUPTAKE-INHIB (SNRIS)
GCN	99452
HICL Sequence Number	035420
HICL Sequence Number Description	DESVENLAFAXINE SUCCINATE
Brand/Generic	Generic
Proprietary Name	Desvenlafaxine
Proprietary Name Suffix	n/a
Non-Proprietary Name	Desvenlafaxine Succinate
Product Type	HUMAN PRESCRIPTION DRUG
Dosage Form	TABLET, EXTENDED RELEASE
Route	ORAL
Active Ingredient Strength	100
Active Ingredient Units	mg/1
Substance Name	DESVENLAFAXINE SUCCINATE
Labeler Name	Breckenridge Pharmaceutical, Inc
Pharmaceutical Class	Cytochrome P450 2D6 Inhibitors [MoA], Norepinephrine Uptake Inhibitors [MoA], Serotonin Uptake Inhibitors [MoA], Serotonin and Norepinephrine Reuptake Inhibitor [EPC]
DEA Schedule	n/a
Marketing Category	ANDA
Application Number	ANDA204003
Listing Certified Through	2024-12-31

Package

NDC 51991-0312-14 (51991031214)

Pricing Information	N/A
NDC Package Code	51991-312-14
Billing NDC	51991031214
Package	14 TABLET, EXTENDED RELEASE in 1 BOTTLE (51991-312-14)
Marketing Start Date	2017-03-01
NDC Exclude Flag	N